BS Identity and Score for Wegovy (Novo Nordisk)

AI-powered evaluation using the Model Context Optimization BS Detection Framework, based solely on publicly available website content.

B
BS Level
Medical Devices, Pharma & Biotech
40.7 Avg BS

Based on 784 businesses audited.

BS Detector

Medical Devices, Pharma & Biotech BS: Wegovy (Novo Nordisk) (wegovy.com)

https://wegovy.com 📍 Industry: Medical Devices, Pharma & Biotech
21 BS / 100

This site is a rare example of high-substance pharma communication that prioritizes clinical metrics over marketing adjectives. The bullshit levels are kept at a minimum by the gravitational pull of FDA compliance and granular trial reporting. It is a benchmark for how to market a complex biological product without resorting to hot air.

Info Density Power-words vs. Substance ratio.
7
23% BS
Semantic Coherence Homepage promise vs. Sub-page reality.
1
5% BS
Trust & Proof Verifiable evidence vs. Trust Theatre.
6
30% BS
Commodity Fingerprint Detection of industry clichés/templates.
5
33% BS
Identity & Authority Expert verifiability & Schema depth.
2
13% BS

Incorporate outbound links to the specific peer-reviewed publications for the 64-week study on ClinicalTrials.gov or PubMed to move from internal proof to external validation. Add Person schema for named ambassadors to provide a verifiable digital footprint for patient stories. Reduce the repetition of the ‘Important Safety Information’ H2 blocks which appear to be a technical artifact of the crawl or site structure, cluttering the heading hierarchy.

Info Density Power-words vs. Substance ratio.
7 Impact Weight: 30 / 100
23% BS

Information density is exceptionally high for a consumer-facing site. Passages like the Wegovy pill results page provide granular data from a 64-week medical study of 307 adults, citing an average 14% body weight loss (~33 lb) and specific discontinuation rates of 18%. The ratio of power words to specific nouns is low, as most headings like ‘What is the most important information I should know?’ are functional rather than promotional fluff.

Most sites "have schema," but AI still cannot understand what their pages represent. Run a Structured Data AI Audit to see what entity types your pages actually resolve into.

Semantic Coherence Homepage promise vs. Sub-page reality.
1 Impact Weight: 20 / 100
5% BS

There is virtually zero semantic drift between the homepage signal and sub-page substance. The homepage H2 ‘Wegovy gives you options’ is directly supported by sub-pages detailing the ‘Meet the Wegovy Pill’ (25 mg tablets) and ‘Meet the Wegovy Pen’ (2.4 mg injection) with corresponding clinical data for each. Messaging remains consistent regarding age restrictions, specifically noting the pill is not approved for adolescents.

Transition from a collection of strings to a machine verifiable identity. Generate your Clinical SEO Strategy to establish a robust Knowledge Graph Topology and eliminate semantic black holes.

Trust & Proof Verifiable evidence vs. Trust Theatre.
6 Impact Weight: 20 / 100
30% BS

The site exhibits minor trust theatre via compensated ‘Wegovy Ambassadors’ (e.g., Keytsiia, Heath, Terry) whose testimonials include efficacy claims. While review_count is high across pages (reaching 7 on the homepage), proof_links_count remains at 0 because these are internal testimonials rather than links to third-party review platforms. However, this is partially neutralized by the required legal transparency regarding patient compensation.

Proof density is high, with a strong ratio of verifiable evidence to assertions. The site provides specific starting weights (235 lb), BMI thresholds (BMI >= 30 kg/m2), and percentage-based outcomes (28% of adults lost 20% or more weight) rather than using vague adjectives like ‘transformative’ or ‘unrivaled.’

For a high volume editorial domain example, open the Search Engine Journal Semantic HTML audit. View the SEJ Semantic HTML Audit to see how template drift and structural noise impact AI chunking.

Commodity Fingerprint Detection of industry clichés/templates.
5 Impact Weight: 15 / 100
33% BS

The site uses standard industry jargon such as ‘FDA approved,’ ‘mechanism of action,’ and ‘clinical trial data,’ but these are technical requirements rather than empty marketing clichés. Boilerplate sections like ‘Frequently Asked Questions’ and ‘Savings and Support’ are present but contain drug-specific answers and genuine financial assistance programs (NovoCare), preventing a high commodity penalty.

Identity & Authority Expert verifiability & Schema depth.
2 Impact Weight: 15 / 100
13% BS

Authority is firmly established through Novo Nordisk’s corporate identity and FDA regulatory markers. While the individual ‘Ambassadors’ lack digital footprints or Person schema (scoring 2 points in authority gaps), the primary authority is the clinical evidence and manufacturer’s pharmacological standing. The technical implementation of schema (MedicalWebPage, Drug) is clean and professional.

There is no disconnect between marketing tone and demonstrated results. Claims of being the ‘only weight-loss medication proven to help reduce the risk of a major heart event’ are backed by the Cardiovascular Results sections and specific drug indications. Unlike generic health sites, every major performance claim is tethered to a specific clinical trial result.

Medical Devices, Pharma & Biotech BS: Wegovy (Novo Nordisk) (wegovy.com)

BS: 21/ 100

This site is a textbook match for the Pharmaceutical and Biotech industry. The content is heavily regulated, featuring mandatory Boxed Warnings, ‘Important Safety Information’ (ISI) blocks, and specific FDA-approved indications for semaglutide.

AI does not interpret your layout visually — it interprets your structure mathematically. Explore the Semantic HTML Technical Framework to understand how heading logic, boundaries, and DOM depth determine what an LLM can retrieve.

“The score of 21 is driven primarily by the 'Trust and Proof' and 'Information Density' pillars. The use of compensated ambassadors and the lack of outbound proof links to independent medical journals prevent a 'Minimal BS' score, while the high specificity of the clinical data prevents it from climbing into the 'Moderate BS' range.”

To understand and learn thinking like AI, visit our educational environment (Wegovy (Novo Nordisk) example) that uses the same data this audit was generated from, and try it yourself.
Verified Analysis Date: June 20, 2026 © 1EuroSEO Independent Evaluator — Non-Sponsored Result
Get a Strategic Holistic View
FREE TOOLS
BUSINESS STRATEGY

Business Intelligence Engine

×
AI VISIBILITY